LCM
IONS icon

Laurion Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Laurion Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-112,300
Closed -$6.46M – 814
2015
Q2 		$6.46M Buy
+112,300
New +$7.14M 0.06% 259

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Laurion Capital Management's IONS Position: Q3 2015 in Review

Laurion Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 112,300 shares — an estimated $6.46M sold.

Laurion Capital Management first reported a position in IONS in Q2 2015 and held it in 1 quarter. The position peaked at $6.46M in Q2 2015. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

  • Laurion Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Laurion Capital Management sold 112,300 Ionis Pharmaceuticals shares in Q3 2015, an estimated $6.46M.
  • Laurion Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Laurion Capital Management's Ionis Pharmaceuticals position peaked at $6.46M in Q2 2015.
  • 314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Laurion Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.